differences between IR-hypophysitis caused by anti-CTLA-4 versus anti-PD-(L)1 monotherapy are described, but the number of patients with IR-hypophysitis caused by anti-CTLA-4/PD-1 combination therapy was too small to analyze, which was the reason for us to perform this study (9). Here, CTLA4 is linked to hypophysitis.